The misreporting of the company ACT's embryonic stem cell research has generated lots of hype but few corrections. Wesley Smith has been connecting the dots.
LINK LINK2 LINK3
It's about money money money...by moving an office branch to Calfornia, ACT will be able to get money from that state's stem cell initiative, and by misstating their stem cells did not kill embryos, they will get money from the feds, and by hyping their experiment in the press, they will get money from investors...
Not bad for a story full of lies.
FINEST KIND CLINIC AND FISHMARKET.... Discussing medicine, culture, and the joys of cooking Pansit.
No comments:
Post a Comment